f.h. faulding &_co. , an australian pharmaceuticals company , said_0 its moleculon inc. affiliate acquired kalipharma inc. for $ 23 million . kalipharma is a new jersey-based pharmaceuticals concern that sells products under the purepac label . faulding said_0 it owns 33_% of moleculon 's voting stock and has an_agreement to_acquire an_additional 19_% . that stake , together with its convertible_preferred stock holdings , gives faulding the right to increase its interest to 70_% of moleculon 's voting stock .